Talking Pandemic

Talking Pandemic

By Akshayata NaiduScienceLife Sciences
Download on the App Store

Talking Pandemic episodes

  • The Deployment

    Description: What will happen when we finally have a vaccine? How can we curtail the spread of the virus with minimum immunization coverage? How are producing these vaccines and how infrastructurally prepared are we in receiving these vaccines? Know all these answers and much more in this episode. Also, know more about GAVI through this link: https://www.gavi.org/our-alliance/about

    ---
    This episode is sponsored by
    · Anchor: The easiest way to make a podcast. https://anchor.fm/app
    47 min
  • The Trial

    We have been hearing about various vaccines entering clinical trials this year. Some are entering phase I and others have gone upto phase III. But why are there so many phases and what do each of them mean while testing the vaccine. My guest joins me today from Mexico to discuss this. After today’s episode I would urge you to look through a paper published in Clinical Infectious diseases Journal in August 2019 and was titled “Principal Controversies in Vaccine Safety in the United States”. It provided a comprehensive view on the controversial theories associated with some of the key vaccines and investigate the weight of these theories. This should give you an idea on the safety profiles of the current vaccines and also on what are we expecting out of the coronavirus vaccine.

    Link for the mentioned article: https://academic.oup.com/cid/article/69/4/726/5316263

    Also a quick update: This episode was recorded about a week ago and hence does not include the discussion on the pause of the phase III clinical trial of the oxford vaccine. 

    ---
    This episode is sponsored by
    · Anchor: The easiest way to make a podcast. https://anchor.fm/app
    32 min
  • The Inception

    In this episode the guest joins me from Spain. We discuss about vaccines and specifically about the oxford vaccine. The paper titled “Safety and Immunogenicity of the ChAdOx1 CoV-19 vaccine against SARS-CoV-2: a preliminary report of phase ½, single-blinded, randomised control trial” was published on the Lancet journal on the 20th of July 2020. Link to the paper: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931604-4

    I have attached the link of the paper with the description. It is based on the results of the Phase 1/2 clinical trial of the oxford vaccine. It would be wonderful if you can have a look at the paper.  We have a special episode for our patreon members where we discuss about the results of the trial in more detail and it will get published on patreon page by tonight.

    In this episode we discuss about the vaccine itself and on how the oxford vaccine group managed to get forward with the vaccine so fast. We also discuss about the results in brief and explore the safety profile of the vaccine. And neither of us are experts in the field of vaccine making but both of us find this process to be very fascinating and would love to share the fascination with all of you. I would also like to request you to send huge applauses to the Jenner Institute and the Oxford vaccine groups and specially the authors of this Lancet paper for such an incredible work. They are real heroes. Let’s find out why!

    ---
    This episode is sponsored by
    · Anchor: The easiest way to make a podcast. https://anchor.fm/app
    32 min
  • Trailer

    Trailer of the show

    ---
    This episode is sponsored by
    · Anchor: The easiest way to make a podcast. https://anchor.fm/app
    2 min

About Talking Pandemic

From the publisher's feed

An initiative to give a voice to young professionals and researchers to talk on how they see the current pandemic and what lessons have they derived from it for the future. The broad purpose of the podcast is to uplift scientific communication to influence a global audience to think about the pandemic more logically and analytically.